NASDAQ:EDGE - Edge Therapeutics, Inc.
$0.42
 $0.02
+4.41%
2:20PM EDT
2019-02-15
Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company's initial product candidates target rare, acute, life-threatening neurological and other conditions. The Company's product candidates utilize its programmable, biodegradable polymer-based development platform (the Precisa Platform), a delivery mechanism that seeks to enable targeted and sustained drug exposure and avoid the dose-limiting side effects associated with the current standards of care. The Company's product candidates include EG-1962 and EG-1964. EG-1962 is a polymer-based microsphere containing nimodipine suspended in a diluent of sodium hyaluronate was developed using its Precisa development platform to improve patient outcomes following aneurysmal subarachnoid hemorrhage (aSAH). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  EDGE     avg for
industry  
  avg for
sector  
42 stocks weight:  38. 73   0. 00   0. 00  
42 stocks rank:  3. 05 K 1. 86 K 1. 09 K
# analyst opinions:  1. 00   14. 92   14. 43  

quick ratio:  5. 50   5. 37   1. 81  
current ratio:  5. 54   5. 69   2. 19  

target price low:  1. 00   88. 97   117. 82  
target price avg:  1. 00   115. 19   141. 96  
target price high:  1. 00   143. 40   163. 16  
1-yr high:  17. 47   124. 30   142. 77  
last close:  0. 39   101. 85   127. 84  
50-day avg:  0. 41   98. 27   122. 46  
200-day avg:  0. 77   99. 72   122. 70  
1-yr low:  0. 31   78. 19   100. 16  
volume:  77. 66 K 2. 38 M 4. 64 M
50-day avg volume:  475. 66 K 3. 31 M 4. 94 M
200-day avg volume:  532. 35 K 3. 23 M 4. 28 M

1-day return:  -2. 50 % 0. 22 % 0. 48 %
this week return:  -9. 30 % 1. 77 % 2. 01 %
12-wk return:  -44. 29 % 6. 56 % 3. 33 %
52-wk return:  -97. 15 % -2. 23 % 14. 35 %

enterprise value (EV):  -23. 94 M 55. 17 B 104. 51 B
market cap:  12. 16 M 49. 01 B 96. 46 B
EBITDA:  -42. 83 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  0. 56   -91. 79   2. 29  
total debt:  0. 00   13. 73 B 16. 57 B
net income (common):  -51. 69 M 2. 37 B 3. 58 B

shares outstanding:  31. 33 M 607. 99 M 1. 22 B
shares:  22. 83 M 605. 53 M 1. 15 B
shares short:  853. 98 K 11. 62 M 12. 55 M
shares short prior month:  882. 24 K 11. 95 M 13. 44 M
short ratio:  1. 76   4. 82   3. 10  
short % of float:  3. 75 % 6. 19 % 2. 82 %
total cash/share:  1. 18   12. 02   11. 46  
total cash:  36. 81 M 7. 41 B 7. 37 B
free cash flow:  -20. 04 M 95. 99 M 2. 04 B
operating cash flow:  -40. 22 M 164. 74 M 3. 04 B

book value:  0. 99   14. 43   28. 26  
price/book:  0. 39   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  -91. 60 % --- ---
1-yr mean volatility:  -0. 64 % 0. 01 % 0. 06 %

1-yr EPS:  -1. 66   3. 03   4. 09  
forward EPS:  -2. 48   4. 33   6. 99  
P/E:  -0. 24   6. 11   26. 91  
forward P/E:  -0. 16   8. 38   10. 48  
PE/G:  0. 00   0. 37   5. 61  
growth:  -75. 66 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -38. 70 % -3. 27 % 3. 81 %
return on equity:  -97. 86 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  1. 13   1. 21   0. 93  
sharpe (1yr):  -1. 27   0. 06   0. 98  

held % insiders:  11. 45 % 6. 46 % 3. 21 %
held % institutions:  32. 22 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : EDGE
.        + 0 =             0 :: INITIAL WEIGHT
.  + 327.004 =       327.004 :: inverse volume-to-price addition
.  + 418.773 =       745.777 :: spline projection addition
.  - 207.134 =       538.643 :: poor performance penalty
.      x 0.4 =       215.283 :: one-year gains+dividend factor
.    x 3.474 =       747.799 :: 13 weeks' performance factor
.    x 1.492 =      1116.081 :: industry recommendation factor
.    x 0.996 =      1111.762 :: return on assets factor
.     x 0.99 =      1100.883 :: return on equity factor
.    x 2.973 =      3273.149 :: current ratio factor
.    x 1.105 =       3618.31 :: quick ratio factor
.    x 1.252 =      4531.103 :: short ratio factor
.    x 2.004 =      9080.075 :: price-to-book factor
.    x 5.603 =     50876.204 :: EBITDA multiple factor
.    x 2.176 =    110707.283 :: P/E weight
.    x 2.209 =    244547.863 :: PE/G factor
.    x 1.544 =     377553.54 :: beta factor
.    x 0.624 =    235599.857 :: sharpe factor
.    x 2.448 =    576697.324 :: target low factor
.    x 1.417 =     817111.07 :: target mean factor
.    x 1.125 =    919302.319 :: target high factor
.    x 1.066 =    979620.324 :: industry 12-weeks return
.      x 1.0 =    979225.547 :: overall "drift" factor
.    x 0.996 =    975239.134 :: largest single-day jump factor
.     x 0.06 =     58084.523 :: low price factor
.      x 1.0 =     58088.421 :: factor hist industry gain for week 06
.   cubeRoot =        38.728 :: reduced for readability
.                     38.728 :: FINAL WEIGHT for NASDAQ:EDGE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org